Abbreviated New Drug Applications and 505(b)(2) Applications

Abbreviated New Drug Applications and 505(b)(2) Applications

OMB: 0910-0786

IC ID: 214783

Information Collection (IC) Details

View Information Collection (IC)

Abbreviated New Drug Applications and 505(b)(2) Applications CDER
 
No Modified
 
Mandatory
 
21 CFR 314.53(f)(1) and (f)(2) 21 CFR 314.60(f) 21 CFR 314.94(a)(12)(viii) 21 CFR 314.95(c) 21 CFR 314.96(c) and (d) 21 CFR 314.97(b) 21 CFR 314.107(e) 21 CFR 314,50(i)(1) and (i)(6) 21 CFR 314.52(a), (b), (c), and (e)  (To search for a specific CFR, visit the Code of Federal Regulations.)

Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Form and Instruction Form FDA 3542 Patent Information Submitted Upon and After Approval of an NDA or Supplement Form FDA 3542 revised draft resulting from Oct 2016 FR.pdf Yes Yes Fillable Fileable
Form and Instruction Form FDA 3542a Patent Information Submitted With the Filing of an NDA, Amendment, or Supplement Form FDA 3542a revised draft resulting from Oct FR 2016.pdf Yes Yes Fillable Fileable

Health Health Care Services

 

1,015 0
   
Private Sector Businesses or other for-profits
 
   100 %

  Approved Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 2,153 0 2,153 0 0 0
Annual IC Time Burden (Hours) 2,789 0 2,789 0 0 0
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Title Document Date Uploaded
No associated records found
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.

© 2024 OMB.report | Privacy Policy